These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35285136)

  • 21. BMP9 induces osteogenesis and adipogenesis in the immortalized human cranial suture progenitors from the patent sutures of craniosynostosis patients.
    Song D; Zhang F; Reid RR; Ye J; Wei Q; Liao J; Zou Y; Fan J; Ma C; Hu X; Qu X; Chen L; Li L; Yu Y; Yu X; Zhang Z; Zhao C; Zeng Z; Zhang R; Yan S; Wu T; Wu X; Shu Y; Lei J; Li Y; Zhang W; Wang J; Lee MJ; Wolf JM; Huang D; He TC
    J Cell Mol Med; 2017 Nov; 21(11):2782-2795. PubMed ID: 28470873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystin-1 surface localization is stimulated by polycystin-2 and cleavage at the G protein-coupled receptor proteolytic site.
    Chapin HC; Rajendran V; Caplan MJ
    Mol Biol Cell; 2010 Dec; 21(24):4338-48. PubMed ID: 20980620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of PKR in the Inhibition of Proliferation and Translation by Polycystin-1.
    Tang Y; Shi G; Yang J; Zheng W; Tang J; Chen XZ; Yang J; Wang Z
    Biomed Res Int; 2019; 2019():5320747. PubMed ID: 31341901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystin-2 induces a conformational change in polycystin-1.
    Oatley P; Talukder MM; Stewart AP; Sandford R; Edwardson JM
    Biochemistry; 2013 Aug; 52(31):5280-7. PubMed ID: 23848298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The polycystic kidney disease 1 (Pkd1) gene is required for the responses of osteochondroprogenitor cells to midpalatal suture expansion in mice.
    Hou B; Kolpakova-Hart E; Fukai N; Wu K; Olsen BR
    Bone; 2009 Jun; 44(6):1121-33. PubMed ID: 19264154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of polycystin-1 ciliary trafficking by motifs at its C-terminus and polycystin-2 but not by cleavage at the GPS site.
    Su X; Wu M; Yao G; El-Jouni W; Luo C; Tabari A; Zhou J
    J Cell Sci; 2015 Nov; 128(22):4063-73. PubMed ID: 26430213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
    Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
    Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3K/Akt promotes feedforward mTORC2 activation through IKKα.
    Dan HC; Antonia RJ; Baldwin AS
    Oncotarget; 2016 Apr; 7(16):21064-75. PubMed ID: 27027448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystin-1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro.
    Zoi I; Gargalionis AN; Papavassiliou KA; Nasiri-Ansari N; Piperi C; Basdra EK; Papavassiliou AG
    J Cell Mol Med; 2022 Mar; 26(5):1699-1709. PubMed ID: 35106909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
    Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model.
    Kramer K; Yang J; Swanson WB; Hayano S; Toda M; Pan H; Kim JK; Krebsbach PH; Mishina Y
    Genesis; 2018 Jun; 56(6-7):e23220. PubMed ID: 30134066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesis.
    Xiao Z; Baudry J; Cao L; Huang J; Chen H; Yates CR; Li W; Dong B; Waters CM; Smith JC; Quarles LD
    J Clin Invest; 2018 Jan; 128(1):157-174. PubMed ID: 29202470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma.
    Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD
    Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
    Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
    Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the cytoplasmic interaction between polycystin-1 and polycystin-2.
    Casuscelli J; Schmidt S; DeGray B; Petri ET; Celić A; Folta-Stogniew E; Ehrlich BE; Boggon TJ
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1310-5. PubMed ID: 19726544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II.
    Xiao Z; Zhang S; Magenheimer BS; Luo J; Quarles LD
    J Biol Chem; 2008 May; 283(18):12624-34. PubMed ID: 18321855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent function of polycystin 1 and polycystin 2 in cell size regulation.
    Viau A; Kotsis F; Boehlke C; Braeg S; Klein M; Nitschke R; Walz G; Kuehn EW
    Biochem Biophys Res Commun; 2020 Jan; 521(2):290-295. PubMed ID: 31668373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration.
    Razmara M; Monazzam A; Skogseid B
    Cell Commun Signal; 2018 Oct; 16(1):64. PubMed ID: 30285764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.